Natixis Advisors, L.P. Zoetis Inc. Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Zoetis Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 855,907 shares of ZTS stock, worth $140 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
855,907
Previous 1,121,306
23.67%
Holding current value
$140 Million
Previous $219 Million
36.35%
% of portfolio
0.26%
Previous 0.43%
Shares
30 transactions
Others Institutions Holding ZTS
# of Institutions
2,064Shares Held
413MCall Options Held
1.22MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA41.4MShares$6.75 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.01 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.24 Billion0.13% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.61 Billion2.4% of portfolio
-
Morgan Stanley New York, NY11.8MShares$1.93 Billion0.14% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $76.4B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...